+
データを開く
-
基本情報
| 登録情報 | データベース: PDB / ID: 9gx0 | ||||||
|---|---|---|---|---|---|---|---|
| タイトル | Human PPAR-gamma ligand binding domain in complex with AKGO79 | ||||||
要素 | Peroxisome proliferator-activated receptor gamma | ||||||
キーワード | TRANSCRIPTION / PPAR / PPAR gamma / PPARg / peroxisome proliferator-activated receptor gamma / nuclear receptor / transcription factor / partial agonist / agonist | ||||||
| 機能・相同性 | 機能・相同性情報prostaglandin receptor activity / : / negative regulation of receptor signaling pathway via STAT / MECP2 regulates transcription factors / negative regulation of vascular endothelial cell proliferation / negative regulation of extracellular matrix assembly / negative regulation of connective tissue replacement involved in inflammatory response wound healing / positive regulation of cholesterol transport / negative regulation of cellular response to transforming growth factor beta stimulus / arachidonate binding ...prostaglandin receptor activity / : / negative regulation of receptor signaling pathway via STAT / MECP2 regulates transcription factors / negative regulation of vascular endothelial cell proliferation / negative regulation of extracellular matrix assembly / negative regulation of connective tissue replacement involved in inflammatory response wound healing / positive regulation of cholesterol transport / negative regulation of cellular response to transforming growth factor beta stimulus / arachidonate binding / positive regulation of adiponectin secretion / negative regulation of cardiac muscle hypertrophy in response to stress / DNA binding domain binding / lipoprotein transport / positive regulation of vascular associated smooth muscle cell apoptotic process / WW domain binding / positive regulation of fatty acid metabolic process / STAT family protein binding / response to lipid / negative regulation of type II interferon-mediated signaling pathway / LBD domain binding / negative regulation of cholesterol storage / negative regulation of SMAD protein signal transduction / lipid homeostasis / E-box binding / alpha-actinin binding / R-SMAD binding / negative regulation of vascular associated smooth muscle cell proliferation / monocyte differentiation / negative regulation of blood vessel endothelial cell migration / white fat cell differentiation / cellular response to low-density lipoprotein particle stimulus / negative regulation of macrophage derived foam cell differentiation / negative regulation of lipid storage / negative regulation of BMP signaling pathway / positive regulation of cholesterol efflux / cell fate commitment / negative regulation of osteoblast differentiation / negative regulation of mitochondrial fission / positive regulation of fat cell differentiation / BMP signaling pathway / long-chain fatty acid transport / nuclear retinoid X receptor binding / Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 / retinoic acid receptor signaling pathway / cell maturation / negative regulation of MAPK cascade / intracellular receptor signaling pathway / hormone-mediated signaling pathway / positive regulation of adipose tissue development / response to nutrient / peroxisome proliferator activated receptor signaling pathway / epithelial cell differentiation / regulation of cellular response to insulin stimulus / peptide binding / negative regulation of miRNA transcription / negative regulation of angiogenesis / placenta development / Regulation of PTEN gene transcription / positive regulation of apoptotic signaling pathway / transcription coregulator binding / SUMOylation of intracellular receptors / negative regulation of smooth muscle cell proliferation / mRNA transcription by RNA polymerase II / negative regulation of transforming growth factor beta receptor signaling pathway / PPARA activates gene expression / fatty acid metabolic process / regulation of circadian rhythm / Nuclear Receptor transcription pathway / Transcriptional regulation of white adipocyte differentiation / lipid metabolic process / positive regulation of miRNA transcription / negative regulation of inflammatory response / DNA-binding transcription repressor activity, RNA polymerase II-specific / regulation of blood pressure / RNA polymerase II transcription regulator complex / nuclear receptor activity / cellular response to insulin stimulus / rhythmic process / glucose homeostasis / MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis / double-stranded DNA binding / DNA-binding transcription activator activity, RNA polymerase II-specific / cellular response to hypoxia / DNA-binding transcription factor binding / sequence-specific DNA binding / nucleic acid binding / DNA-binding transcription factor activity, RNA polymerase II-specific / cell differentiation / receptor complex / transcription cis-regulatory region binding / RNA polymerase II cis-regulatory region sequence-specific DNA binding / DNA-binding transcription factor activity / negative regulation of gene expression / innate immune response / negative regulation of DNA-templated transcription / intracellular membrane-bounded organelle / chromatin binding / positive regulation of gene expression / regulation of transcription by RNA polymerase II 類似検索 - 分子機能 | ||||||
| 生物種 | Homo sapiens (ヒト) | ||||||
| 手法 | X線回折 / シンクロトロン / 分子置換 / 解像度: 2.1 Å | ||||||
データ登録者 | Koops, A.A. / Oerlemans, G.J.M. / Brunsveld, L. | ||||||
| 資金援助 | オランダ, 1件
| ||||||
引用 | ジャーナル: To Be Publishedタイトル: Development and characterization of novel indazole-based PPAR-gamma partial agonists 著者: Koops, A.A. / Oerlemans, G.J.M. / Brunsveld, L. | ||||||
| 履歴 |
|
-
構造の表示
| 構造ビューア | 分子: Molmil Jmol/JSmol |
|---|
-
ダウンロードとリンク
-
ダウンロード
| PDBx/mmCIF形式 | 9gx0.cif.gz | 263.9 KB | 表示 | PDBx/mmCIF形式 |
|---|---|---|---|---|
| PDB形式 | pdb9gx0.ent.gz | 表示 | PDB形式 | |
| PDBx/mmJSON形式 | 9gx0.json.gz | ツリー表示 | PDBx/mmJSON形式 | |
| その他 | その他のダウンロード |
-検証レポート
| アーカイブディレクトリ | https://data.pdbj.org/pub/pdb/validation_reports/gx/9gx0 ftp://data.pdbj.org/pub/pdb/validation_reports/gx/9gx0 | HTTPS FTP |
|---|
-関連構造データ
| 関連構造データ | ![]() 9gfuC ![]() 9gvpC ![]() 9gvsC ![]() 9gw3C ![]() 9gw4C ![]() 9gw7C ![]() 9gw8C ![]() 9gwbC ![]() 9gwcC ![]() 9gweC ![]() 9gwfC ![]() 9gwgC ![]() 9gwhC ![]() 9gwiC ![]() 9gwkC ![]() 9gwlC ![]() 9gwmC ![]() 9gwnC ![]() 9gwpC ![]() 9gwqC ![]() 9gwrC ![]() 9gwsC ![]() 9gwxC ![]() 9gwyC ![]() 9gx1C ![]() 9gx2C ![]() 9gx3C ![]() 9gx4C ![]() 9gx5C ![]() 9gx6C ![]() 9gx7C ![]() 9gxdC ![]() 9gz7C ![]() 9gz8C ![]() 9gz9C ![]() 9gzaC ![]() 9gzbC ![]() 9gzcC ![]() 9gzeC ![]() 9gzfC ![]() 9gziC C: 同じ文献を引用 ( |
|---|---|
| 類似構造データ | 類似検索 - 機能・相同性 F&H 検索 |
| 実験データセット #1 | データ参照: 10.15151/ESRF-ES-1119943221 / データの種類: diffraction image data |
-
リンク
-
集合体
| 登録構造単位 | ![]()
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 単位格子 |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 非結晶学的対称性 (NCS) | NCSドメイン:
NCSドメイン領域: Ens-ID: ens_1
NCS oper: (Code: givenMatrix: (0.10784775430032, 0.98099042509205, 0.16132776503161), (0.98483611403237, -0.12760063714041, 0.11754108175008), (0.13589220135826, 0.14620486749449, -0.9798762403135) ...NCS oper: (Code: given Matrix: (0.10784775430032, 0.98099042509205, 0.16132776503161), ベクター: |
-
要素
| #1: タンパク質 | 分子量: 31410.488 Da / 分子数: 2 / 由来タイプ: 組換発現 / 詳細: N-terminal GSHM left from Thrombin cleavage / 由来: (組換発現) Homo sapiens (ヒト) / 遺伝子: PPARG, NR1C3 / 発現宿主: ![]() #2: 化合物 | 分子量: 599.384 Da / 分子数: 2 / 由来タイプ: 合成 / 式: C30H19Cl2F3N2O4 / タイプ: SUBJECT OF INVESTIGATION #3: 水 | ChemComp-HOH / | 研究の焦点であるリガンドがあるか | Y | Has protein modification | N | |
|---|
-実験情報
-実験
| 実験 | 手法: X線回折 / 使用した結晶の数: 1 |
|---|
-
試料調製
| 結晶 | マシュー密度: 2.68 Å3/Da / 溶媒含有率: 54.04 % |
|---|---|
| 結晶化 | 温度: 298 K / 手法: 蒸気拡散法, シッティングドロップ法 詳細: 0.9M-1.2M sodium citrate tribasic dihydrate, 0.1M sodium cacodylate PH範囲: 6.4-7.4 |
-データ収集
| 回折 | 平均測定温度: 100 K / Serial crystal experiment: N |
|---|---|
| 放射光源 | 由来: シンクロトロン / サイト: ESRF / ビームライン: MASSIF-1 / 波長: 0.967697 Å |
| 検出器 | タイプ: DECTRIS EIGER X 4M / 検出器: PIXEL / 日付: 2023年7月12日 |
| 放射 | モノクロメーター: Si(111) / プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
| 放射波長 | 波長: 0.967697 Å / 相対比: 1 |
| 反射 | 解像度: 2.1→45.09 Å / Num. obs: 38274 / % possible obs: 98.2 % / 冗長度: 7.1 % / Biso Wilson estimate: 46.41 Å2 / CC1/2: 0.993 / Net I/σ(I): 13.9 |
| 反射 シェル | 解像度: 2.1→2.16 Å / Mean I/σ(I) obs: 1.9 / Num. unique obs: 3124 / CC1/2: 0.935 |
-
解析
| ソフトウェア |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 精密化 | 構造決定の手法: 分子置換 / 解像度: 2.1→45.09 Å / SU ML: 0.3012 / 交差検証法: FREE R-VALUE / σ(F): 1.35 / 位相誤差: 29.8862 立体化学のターゲット値: GeoStd + Monomer Library + CDL v1.2
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 溶媒の処理 | 減衰半径: 0.9 Å / VDWプローブ半径: 1.1 Å / 溶媒モデル: FLAT BULK SOLVENT MODEL | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 原子変位パラメータ | Biso mean: 61.4 Å2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 精密化ステップ | サイクル: LAST / 解像度: 2.1→45.09 Å
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 拘束条件 |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refine LS restraints NCS | タイプ: Torsion NCS / Rms dev position: 2.2149458914783 Å | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LS精密化 シェル |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 精密化 TLS | 手法: refined / Refine-ID: X-RAY DIFFRACTION
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 精密化 TLSグループ | Refine-ID: X-RAY DIFFRACTION / Auth seq-ID: 233 - 601 / Label seq-ID: 1
|
ムービー
コントローラー
万見について




Homo sapiens (ヒト)
X線回折
オランダ, 1件
引用








































PDBj



